Health

Sisram Medical to Report H1 2024 Financial Results on August 21 and Hold a Conference Call on August 22

H1 2024 conference call to be held on August 22, at 8:30 a.m. Eastern Time HONG KONG, Aug. 15, 2024 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", stock code: 1696.HK; together with its subsidiaries referred as the " Group"), a global consumer wellness group featuring a first-of-it...

2024-08-15 09:00 3202

Ivonescimab (PD-1/VEGF) Received Priority Review from China's NMPA for First-Line Treatment of PD-L1 Positive NSCLC

The Second Indication of Ivonescimab in NSCLC 2L+ EGFRm NSCLC Already Approved in May 2024 HONG KONG, Aug. 14, 2024 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926.HK) ("Akeso,") today announced that the National Center for Drug Evaluation of the State Drug Administration ofthe People's Republic of China...

2024-08-15 07:30 1700

REMOVERY TO PROVIDE 150 FREE TATTOO REMOVAL PACKAGES TO COMMEMORATE THE INAUGURAL WORLD TATTOO REMOVAL DAY

On August 14, the world's tattoo removal experts will provide 150 treatments to individuals in need across their global studio locations AUSTIN, Texas, Aug. 14, 2024 /PRNewswire/ -- To bring awareness to the safety, efficacy and accessibility of tattoo removal treatment,Removery is presenting th...

2024-08-14 22:13 1897

Strategic Partnership Between Beyond Medical Group (Singapore) and SingMed Medical Centre (Cambodia) Enhances Healthcare Collaboration

Beyond Medical Pledges to Join Forces with SingMed to Enhance Access to Healthcare and Elevate Care Standards Across Both Regions SINGAPORE, Aug. 14, 2024 /PRNewswire/ -- Beyond Medical Group Singapore and SingMed (Phnom Penh, Cambodia) proudly announce the signin...

2024-08-14 12:39 2002

Novo AI to Cut Costs and Boost Efficiency For Insurance Companies

SINGAPORE, Aug. 14, 2024 /PRNewswire/ -- Novo AI, founded by ex-Googlers and backed by First Round Capital, is revolutionizing the insurance industry with advanced generative AI technology. Their innovative solution is set to redefine operational efficiencies and profitability for insurance compa...

2024-08-14 08:30 2828

LBB Specialties Expands into Puerto Rico and Latin America to Serve Growing Life Sciences Market

NORWALK, Conn., Aug. 13, 2024 /PRNewswire/ -- LBB Specialties (LBBS), a leading North American distributor of specialty chemicals and ingredients, today announced its strategic expansion into thePuerto Rico and Latin America Life Sciences markets. This move underscores LBB Specialties' commitment...

2024-08-13 23:00 1700

Public Interest Registry Announces 2024 .ORG Impact Awards Finalists, Emmy & Tony Award Winner Alan Cumming to Host

35 innovative, mission-driven organizations and changemakers selected from over 1,700 applicants from more than 87 countries RESTON, Va., Aug. 13, 2024 /PRNewswire/ -- Public Interest Registry (PIR), the people behind the .ORG domain, named the finalists for the 6th annual.ORG Impact Awards...

2024-08-13 22:00 2840

AWESum Care welcomes Mr. John Tsang as its first ambassador

HONG KONG, Aug. 13, 2024 /PRNewswire/ -- AWESum Care is pleased to announce that Mr.John Tsang, the former Financial Secretary, will serve as the first ambassador of the social enterprise. Mr Tsang has always been committed to promoting social welfare and firmly believes in the importance of Adva...

2024-08-13 21:18 2219

Alfred Health Enhances Cancer Patient Care with Oracle Health

Leading Victorian healthcare network integrates oncology and EHR solutions to deliver more informed care across its locations AUSTIN, Texas and VICTORIA, Australia, Aug. 13, 2024 /PRNewswire/ -- Leading Victorian healthcare network, Alfred Health, has extended its long-standing Oracle Health foo...

2024-08-13 21:00 1548

Qilian International Holding Group Ltd. Announces Trading Ticker Symbol to "BGM"

CHENGDU, China, Aug. 13, 2024 /PRNewswire/ -- Qilian International Holding Group Ltd. ("Qilian" or the "Company") (NASDAQ: QLI), aChina-based pharmaceutical and chemical products manufacturer, announced today that effective onAugust 11, 2024, its Class A ordinary shares will begin trading on the...

2024-08-13 20:00 2693

Sinch AI Used to Safely Pre-Triage Patients

STOCKHOLM, Aug. 13, 2024 /PRNewswire/ -- Sinch  (Sinch AB (publ) – XSTO: SINCH), which is pioneering the way the world communicates through its Customer Communications Cloud, is excited to announce that MINDD, a Dutch medical technology company, has selected Sinch to develop an advanced AI-driven...

2024-08-13 15:51 1506

Australian biotech incubator Proto Axiom announces $20M Series B first close

$20M unlocked for opportunities in Australian biotech innovation, valuing Proto Axiom at$90M SYDNEY, Aug. 13, 2024 /PRNewswire/ -- Proto Axiom, the Australian biomedical technology incubator has today announced a$20 million first close of its targeted$30 million Series B, to bolster Australia's...

2024-08-13 10:21 2552

Docquity Drives Demand for SIT Pharma's Duo Probiotics in Thailand, Achieving 31% Sales Growth in 6 months

* Docquity's Awareness to Advocacy (A2A) Program and strong local distribution network enabled SIT's duo probiotic sales to surpass the market growth rate of 15% * The technology platform boosted SIT's HCP education efforts, more than doubling its reach to 2,000 HCPs within six months and aim...

2024-08-13 10:00 1999

Registrational Phase III Study of Lisaftoclax in Newly-Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome Cleared by China CDE

ROCKVILLE, Md. and SUZHOU, China, Aug. 13, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing both first- and best-in-class therapies for malignancies, announced today it has been cleared by the Ce...

2024-08-13 09:52 2121

Chang Gung Cancer Proton Therapy Achieves Breakthrough

Research Confirms Effective Control of Large Liver Cancer, Doubling Survival Time Published in the International Journal of Radiation Oncology TAOYUAN, Aug. 13, 2024 /PRNewswire/ -- With cancer incidence on the rise, pro...

2024-08-13 09:03 1991

Biosyngen's BRG01 Receives FDA Approval for Phase II Clinical Trial

SINGAPORE, Aug. 13, 2024 /PRNewswire/ -- Biosyngen is proud to announce that the U.S. Food and Drug Administration (FDA) has approved its BRG01, an EBV-specific CAR-T cell therapy, to proceed with a pivotal Phase lI clinical trial.This marks the first cell therapy to enter Phase lI trials in both...

2024-08-13 09:00 1775

Pantai Hospital Kuala Lumpur Introduces Outpatient Parenteral Antimicrobial Therapy (OPAT) for Improved Patient Care

KUALA LUMPUR, Malaysia, Aug. 12, 2024 /PRNewswire/ -- Pantai Hospital Kuala Lumpur (PHKL) has officially introduced its Outpatient Parenteral Antimicrobial Therapy (OPAT) service, offering an innovative treatment option that enhances patient care.

2024-08-13 08:53 1929

AI in the IVF Process is the Standard of Care at Virtus Fertility Centre Singapore

The technology developed by Virtus Health's scientists contributes to IVF medicine by shortening the time to a successful pregnancy and improving overall success rates. SINGAPORE, Aug. 13, 2024 /PRNewswire/ -- Virtus Fertility Centre Singapore (VFCS) announced that artificial intelligence (AI), ...

2024-08-13 08:44 1781

MediPortal Introduces AI for Practice Management in Australia

PERTH, Australia, Aug. 13, 2024 /PRNewswire/ -- MediPortal PTY LTD. (MediPortal) has launched an AI-powered practice intelligence platform for Australian medical practices, aiming to enhance efficiency and patient care. Developed as the brainchild of a practising general practitioner, this innov...

2024-08-13 08:30 1839

Lynk Pharmaceuticals Announces Positive Results from Phase 1b Clinical Study of LNK01004 for the Treatment of Atopic Dermatitis

HANGZHOU, China and SHANGHAI and BOSTON, Aug. 13, 2024 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical-stage innovative drug development company, announced positive results from its Phase1b clinical study of LNK01004, a skin restricte...

2024-08-13 08:00 1825
1 ... 44454647484950 ... 858